Insider Stock Trading History of Gleeson Christopher M


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Gleeson Christopher M since year 2005. The trader's CIK number is 1134540. At the time of this reporting, Gleeson Christopher M is the President & CEO of Genmark Diagnostics, Inc. . (stock ticker symbol GNMK). See this page for all insider trading activities at Genmark Diagnostics, Inc. .

Note that in the past GLEESON CHRISTOPHER M also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Gleeson Christopher M since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-03-20 GNMK Genmark Diagnostics, Inc. Sale 16,000 11.56 184,960
2013-03-18 GNMK Genmark Diagnostics, Inc. Sale 17,000 11.80 200,600
2013-03-15 GNMK Genmark Diagnostics, Inc. Sale 17,000 11.93 202,810
2012-06-26 GNMK Genmark Diagnostics, Inc. Buy 60,000 4.20 252,000
2011-03-16 GNMK Genmark Diagnostics, Inc. Buy 15,000 4.00 60,000
2010-06-03 GNMK Genmark Diagnostics, Inc. Buy 1,333,333 6.00 7,999,998
2008-02-07 VMSI Ventana Medical Systems Inc Option Ex 516,305 89.40 46,157,667
2008-01-28 VMSI Ventana Medical Systems Inc Option Ex 11,104 10.09 112,039
2007-02-13 VMSI Ventana Medical Systems Inc Option Ex 20,000 259.43 5,188,540
2006-12-15 VMSI Ventana Medical Systems Inc Option Ex 20,598 8.84 182,168
2006-04-28 VMSI Ventana Medical Systems Inc Option Ex 80,000 8.94 715,040
2006-04-28 VMSI Ventana Medical Systems Inc Sale 80,000 45.03 3,602,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gleeson Christopher M (President & CEO of Genmark Diagnostics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.